The study is being conducted under a USFDA IND, has received U.S. Fast Track Designation for SLE-ITP, and has obtained IND approval from China’s Center for Drug Evaluation
The trial will evaluate safety endpoints including dose-limiting toxicities and adverse events
Phase 1 dosing is expected to finish by the end of 2025
Cysoni is a bionic device that paces the heart with real-time respiratory modulation
The primary objective of this Phase 1 study is to investigate the safety and tolerability of GZR18 in healthy volunteers
MultiTEP Platform-based vaccine targeting three B cell epitopes of pathological ?-Synuclein simultaneously shows protective efficacy in mouse model of synucleinopathies
The goal is to better support drug developers as programs move from laboratory research into clinical trials
The expansion builds on Veristat’s work helping Chinese pharmaceutical firms such as Hansoh Pharma and CStone Pharmaceuticals
The mPTP plays a key role in mitochondrial dysfunction, inflammation, and neuronal death in neurodegenerative diseases
The work will leverage ProBioGen’s CHO.RiGHT expression platform, powered by its proprietary DirectedLuck transposase technology, alongside PsiBot smart automation
Subscribe To Our Newsletter & Stay Updated
